RIDEAU
DEAD

Serial Number

88425738

Owner

Aphria Inc.

Attorney

Courtney Thompson

Filing Date

May 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RIDEAU Trademark

Serial Number: 88425738

RIDEAU is a trademark filed by Aphria Inc. on May 10, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 31 (Natural Agricultural Products), Class 34 (Smokers Articles). The application is currently no longer active.

Owner Contact Info

Aphria Inc. (125 trademarks)

265 Talbot Street West
Leamington, Ontario N8H4H3 , CA

Entity Type: 99

Trademark Details

Filing Date

May 10, 2019

Registration Date

Not Registered

Goods & Services

Oils derived from hemp for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; food products containing hemp, resins, and oils, namely, butter, fruit based energy food bars, seed and nut-based energy food bars; processed edible hemp seeds; all of the foregoing comprised of hemp with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Medicated bath salts; medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely, medicinal oils and salves; concentrated medicated pastes for the teeth and gums, for the hair and scalp, and for use on skin rashes; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, salves, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp derivatives for medicinal use; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing comprised of Cannabis sativa L with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Dried hemp for smoking; derivatives of hemp, namely, processed resins and oils, not including essential oils, in the nature of liquids for use in electronic cigarettes and oral smokeless vaporizers; e-liquids comprised of hemp derivatives, not including essential oils, for use in electronic cigarettes and oral smokeless vaporizers for recreational use; all of the foregoing comprised of hemp with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD; smokers' articles, namely, smoking pipes, oral vaporizers for smokers and grinders for use with hemp with all the foregoing exclusively for use with goods comprised of hemp having a delta-9 THC concentration of not more than 0.3% dry weight basis and smokers' articles, namely, pouches for use with hemp, lighters for smokers

Live hemp plants; hemp seeds for planting and agricultural use; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis

Filing History

ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Apr 22, 2022 MAB3
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Apr 22, 2022 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Apr 4, 2022 ABN3
EXPARTE APPEAL TERMINATED
Apr 4, 2022 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Feb 23, 2022 EXFB
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Dec 10, 2021 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Dec 10, 2021 GECD
ACTION CONTINUING FINAL - COMPLETED
Dec 10, 2021 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 9, 2021 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 9, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 9, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 9, 2021 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 9, 2021 GNFN
FINAL REFUSAL E-MAILED
Feb 9, 2021 GNFR
FINAL REFUSAL WRITTEN
Feb 9, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 11, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 11, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 11, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2020 CRFA
ASSIGNED TO LIE
Apr 23, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 19, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 18, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 18, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 18, 2019 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 17, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 17, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 17, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 15, 2019 DOCK
ASSIGNED TO EXAMINER
May 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2019 NWOS
NEW APPLICATION ENTERED
May 14, 2019 NWAP